{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:37:26Z","timestamp":1770525446762,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,5,12]],"date-time":"2013-05-12T00:00:00Z","timestamp":1368316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s12253-013-9644-y","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T04:05:01Z","timestamp":1368245101000},"page":"365-373","source":"Crossref","is-referenced-by-count":48,"title":["Merlin, the NF2 Gene Product"],"prefix":"10.1007","volume":"19","author":[{"given":"Nives","family":"Pe\u0107ina-\u0160laus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,12]]},"reference":[{"key":"9644_CR1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363:515\u2013521","journal-title":"Nature"},{"key":"9644_CR2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791\u2013800","journal-title":"Cell"},{"key":"9644_CR3","first-page":"M29","volume":"1423","author":"JF Gusella","year":"1999","unstructured":"Gusella JF, Ramesh V, MacCollin M, Jacoby LB (1999) Merlin: the neurofibromatosis 2 tumor suppressor. Biochim Biophys Acta 1423:M29\u2013M36","journal-title":"Biochim Biophys Acta"},{"key":"9644_CR4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138920310791824011","volume":"11","author":"I Stamenkovic","year":"2010","unstructured":"Stamenkovic I, Yu Q (2010) Merlin, a \u201cmagic\u201d linker between the extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival. Curr Protein Pept Sci 11:471\u2013484","journal-title":"Curr Protein Pept Sci"},{"key":"9644_CR5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3171\/2009.10.JNS091135","volume":"114","author":"MI Sughrue","year":"2011","unstructured":"Sughrue MI, Yeung AH, Rutkowski MJ, Cheung SW, Parsa AT (2011) Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. J Neurosurg 114:359\u2013366","journal-title":"J Neurosurg"},{"key":"9644_CR6","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1038\/nrneurol.2011.82","volume":"7","author":"S Ammoun","year":"2011","unstructured":"Ammoun S, Hanemann CO (2011) Emerging therapeutic targets in schwannomas and other merlin-deficient tumors. Nat Rev Neurol 7:3992\u20133999","journal-title":"Nat Rev Neurol"},{"key":"9644_CR7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.febslet.2012.03.016","volume":"586","author":"L Zhou","year":"2012","unstructured":"Zhou L, Hanemann CO (2012) Merlin, a multi-suppressor from cell membrane to the nucleus. FEBS Lett 586:1403\u20131408","journal-title":"FEBS Lett"},{"key":"9644_CR8","unstructured":"Entrez, the life science search engine ( http:\/\/www.ncbi.nlm.nih.gov\/sites\/gquery )"},{"key":"9644_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.pathol.2.010506.091940","volume":"2","author":"AI McClatchey","year":"2007","unstructured":"McClatchey AI (2007) Neurofibromatosis. Annu Rev Pathol Mech Dis 2:191\u2013216","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"9644_CR10","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1074\/jbc.M109979200","volume":"277","author":"T Shimizu","year":"2002","unstructured":"Shimizu T, Seto A, Maita N, Hamada K, Tsukita S, Hakoshima T (2002) Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain. J Biol Chem 277:10332\u201310336","journal-title":"J Biol Chem"},{"key":"9644_CR11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awm249","volume":"131","author":"CO Hanemann","year":"2008","unstructured":"Hanemann CO (2008) Magic but treatable? Tumours due to loss of Merlin. Brain 131:606\u2013615","journal-title":"Brain"},{"key":"9644_CR12","unstructured":"UniProtKB\/Swiss-Prot ( http:\/\/www.uniprot.org\/uniprot\/P35240#section_comments )"},{"key":"9644_CR13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1111\/j.1582-4934.2012.01525.x","volume":"16","author":"M Laulajainen","year":"2012","unstructured":"Laulajainen M, Melikova M, Muranen T, Carpen O, Gronholm M (2012) Dictinct overlapping sequences at the carboxy-terminus of merlin regulate its tumor suppressor and morphogenic activity. J Cell Mol Med 16:2161\u20132175","journal-title":"J Cell Mol Med"},{"key":"9644_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-011-0928-6","volume":"123","author":"SL Carroll","year":"2012","unstructured":"Carroll SL (2012) Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms. Acta Neuropathol 123:321\u2013348","journal-title":"Acta Neuropathol"},{"key":"9644_CR15","doi-asserted-by":"crossref","first-page":"18559","DOI":"10.1074\/jbc.M313916200","volume":"279","author":"K Alfthan","year":"2004","unstructured":"Alfthan K, Heiska L, Gr\u00f6nholm M, Renkema GH, Carp\u00e9n O (2004) Cyclic AMP-demendent protein kinase phosphorylates merlin at serine 518 independently of p21 activated kinase and promotes merlin-ezrin heterodimerization. J Biol Chem 279:18559\u201318566","journal-title":"J Biol Chem"},{"key":"9644_CR16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.11.10.1253","volume":"11","author":"AI McClatchey","year":"1997","unstructured":"McClatchey AI, Saotome I, Ramesh V, Gusella JF, Jacks T (1997) The NF2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev 11:1253\u20131265","journal-title":"Genes Dev"},{"key":"9644_CR17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00415-006-0347-0","volume":"253","author":"CO Hanemann","year":"2006","unstructured":"Hanemann CO, Evans DG (2006) News on the genetics, epidemiology, medical care and translational research of Schwannomas. J Neurol 253:1533\u20131541","journal-title":"J Neurol"},{"key":"9644_CR18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","volume":"14","author":"M Giovannini","year":"2000","unstructured":"Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G (2000) Conditional biallelic NF2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:1617\u20131630","journal-title":"Genes Dev"},{"key":"9644_CR19","first-page":"2270","volume":"55","author":"M Lutchman","year":"1995","unstructured":"Lutchman M, Rouleau GA (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 55:2270\u20132274","journal-title":"Cancer Res"},{"key":"9644_CR20","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1016\/S0021-9258(17)31525-9","volume":"269","author":"A Tikoo","year":"1994","unstructured":"Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H (1994) An anti-Ras function of neurofibromatosis type 2 gene product (NF2\/Merlin). J Biol Chem 269:23387\u201323390","journal-title":"J Biol Chem"},{"key":"9644_CR21","first-page":"32","volume":"1785","author":"DR Scoles","year":"2008","unstructured":"Scoles DR (2008) The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochim Biophys Acta 1785:32\u201354","journal-title":"Biochim Biophys Acta"},{"key":"9644_CR22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","volume":"15","author":"H Morrison","year":"2001","unstructured":"Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968\u2013980","journal-title":"Genes Dev"},{"key":"9644_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1083\/jcb.200503165","volume":"171","author":"T Okada","year":"2005","unstructured":"Okada T, Lopez-Lago M, Giancotti FG (2005) Merlin\/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol 171:361\u2013371","journal-title":"J Cell Biol"},{"key":"9644_CR24","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1101\/gad.1054603","volume":"17","author":"D Lallemand","year":"2003","unstructured":"Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI (2003) NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17:1090\u20131100","journal-title":"Genes Dev"},{"key":"9644_CR25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/embor.2012.11","volume":"13","author":"W Li","year":"2012","unstructured":"Li W, Cooper J, Karajannis MA, Giancotti FG (2012) Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus. EMBO Rep 13:204\u2013215","journal-title":"EMBO Rep"},{"key":"9644_CR26","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1074\/jbc.M305526200","volume":"279","author":"H Kim","year":"2004","unstructured":"Kim H, Kwak NJ, Lee JY, Choi BH, Lim Y, Ko YJ, Kim YH, Huh PW, Lee KH, Rha HK, Wang YP (2004) Merlin neutralizes the inhibitory effect of Mdm2 on p53. J Biol Chem 279:7812\u20137818","journal-title":"J Biol Chem"},{"key":"9644_CR27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng930","volume":"31","author":"C Fernandez-Valle","year":"2002","unstructured":"Fernandez-Valle C, Tang Y, Ricard J, Rodenas-Ruano A, Taylor A, Hackler E, Biggerstaff J, Iacovelli J (2002) Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31:354\u2013362","journal-title":"Nat Genet"},{"key":"9644_CR28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","volume":"67","author":"H Morrison","year":"2007","unstructured":"Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P (2007) Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67:520\u2013527","journal-title":"Cancer Res"},{"key":"9644_CR29","first-page":"1493","volume":"23","author":"JT Fraenzer","year":"2003","unstructured":"Fraenzer JT, Pan H, Minimo L Jr, Smith GM, Knauer D, Hung G (2003) Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int J Oncol 23:1493\u20131500","journal-title":"Int J Oncol"},{"key":"9644_CR30","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1158\/0008-5472.CAN-08-3931","volume":"69","author":"M Okada","year":"2009","unstructured":"Okada M, Wang Y, Jang SW, Tang X, Neri LM, Ye K (2009) Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin. Cancer Res 69:4043\u20134051","journal-title":"Cancer Res"},{"key":"9644_CR31","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/onc.2010.20","volume":"29","author":"EE Bosco","year":"2010","unstructured":"Bosco EE, Nakai Y, Hennigan RF, Ratner N, Zheng Y (2010) NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation. Oncogene 29:2540\u20132549","journal-title":"Oncogene"},{"key":"9644_CR32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1593\/neo.111060","volume":"13","author":"L Zhou","year":"2011","unstructured":"Zhou L, Ercolano E, Ammoun S, Schmid MC, Barczyk MA, Hanemann CO (2011) Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt\/\u03b2-Catenin signaling linked to the PDGFR\/Src and Rac\/PAK pathways. Neoplasia 13:1101\u20131112","journal-title":"Neoplasia"},{"key":"9644_CR33","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/0008-5472.CAN-08-0190","volume":"68","author":"YKI Lau","year":"2008","unstructured":"Lau YKI, Murray LB, Houshmandi SS, Nu Y, Gutmann DH, Yu Q (2008) Merlin is a potent inhibitor of glioma growth. Cancer Res 68:5733\u20135742","journal-title":"Cancer Res"},{"key":"9644_CR34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","volume":"29","author":"DG Evans","year":"1992","unstructured":"Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841\u2013846","journal-title":"J Med Genet"},{"key":"9644_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2","volume":"17","author":"LB Jacoby","year":"1996","unstructured":"Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF (1996) Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosom Cancer 17:45\u201355","journal-title":"Genes Chromosom Cancer"},{"key":"9644_CR36","first-page":"754","volume":"18","author":"RM Irving","year":"1997","unstructured":"Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER (1997) Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma. Am J Otol 18:754\u2013760","journal-title":"Am J Otol"},{"key":"9644_CR37","unstructured":"The Human Gene Mutation Database ( http:\/\/www.hgmd.cf.ac.uk\/ac\/gene.php?gene=NF2 )"},{"key":"9644_CR38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s007010070036","volume":"142","author":"J Antinheimo","year":"2000","unstructured":"Antinheimo J, Sallinen SL, Sallinen P, Haapasalo H, Helin H, Horelli-Kuitunen N, Wessman M, Sainio M, J\u00e4\u00e4skel\u00e4inen J, Carp\u00e9n O (2000) Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated Schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir 142:1099\u20131105","journal-title":"Acta Neurochir"},{"key":"9644_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/humu.20393","volume":"28","author":"I Ahronowitz","year":"2007","unstructured":"Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP (2007) Mutational spectrum of NF2 gene: a meta-analysis of 12\u00a0years of research and diagnostic laboratory findings. Hum Mutat 28:1\u201312","journal-title":"Hum Mutat"},{"key":"9644_CR40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mhn.2000.107683","volume":"123","author":"DB Welling","year":"2000","unstructured":"Welling DB, Akhmametyeva EM, Daniels RL, Lasak JM, Zhu L, Miles-Markley BA, Chang LS (2000) Analysis of the human neurofibromatosis type 2 gene promoter and its expression. Otolaryngology 123:413\u2013418","journal-title":"Otolaryngology"},{"key":"9644_CR41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","volume":"7","author":"DH Gutmann","year":"1998","unstructured":"Gutmann DH, Geist RT, Xu H, Kim JS, Saporito-Irwin S (1998) Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum Mol Genet 7:335\u2013345","journal-title":"Hum Mol Genet"},{"key":"9644_CR42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3171\/2011.6.JNS11131","volume":"115","author":"B Fong","year":"2011","unstructured":"Fong B, Barkhoudarian G, Pezeshkian P, Parsa AT, Gopen Q, Yang I (2011) The molecular biology and novel treatments of vestibular schwannomas. J Neurosurg 115:906\u2013914","journal-title":"J Neurosurg"},{"key":"9644_CR43","first-page":"152","volume-title":"WHO classification of tumours of the central nervous system","author":"BW Scheithauer","year":"2007","unstructured":"Scheithauer BW, Louis DN, Hunter S, Woodruff JM, Antonescu CR (2007) Tumours of the cranial and paraspinal nerves. Schwannoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, pp 152\u2013155","edition":"4"},{"key":"9644_CR44","first-page":"97","volume":"29","author":"A Ghosh","year":"2010","unstructured":"Ghosh A, Talwar OP, Pradhan SV (2010) Tumour and tumour-like conditions of peripheral nerve origin: ten years\u2019 experience. Kathmandu Univ Med J 29:97\u2013101","journal-title":"Kathmandu Univ Med J"},{"key":"9644_CR45","doi-asserted-by":"crossref","unstructured":"Celis-Aguilar E, Lassaletta L, Torres-Martin M, Rodrigues FY, Nistal M, Castresana JS, Gavilan J, Ray JA (2012) The molecular biology of vestibular schwannomas and its association with hearing loss: a review. Genet Res Int. Article ID 856157:10. doi: 10.1155\/2012\/856157","DOI":"10.1155\/2012\/856157"},{"key":"9644_CR46","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/archotol.1993.01880230066011","volume":"119","author":"RM Irving","year":"1993","unstructured":"Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER (1993) Molecular genetic analysis of the mechanism of tumorigenesis in acoustic neuroma. Arch Otolaryngol Head Neck Surg 119:1222\u20131228","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"9644_CR47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s004010050608","volume":"93","author":"T Hitotsumatsu","year":"1997","unstructured":"Hitotsumatsu T, Iwaki T, Kitamoto T, Mizoguchi M, Suzuki SO, Hamada Y, Fukui M, Tateishi J (1997) Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol 93:225\u2013232","journal-title":"Acta Neuropathol"},{"key":"9644_CR48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.mao.0000199753.44191.73","volume":"27","author":"DJ Lee","year":"2006","unstructured":"Lee DJ, Maseyesva B, Westra W, Long D, Niparko JK, Califano J (2006) Microsatellite analysis of recurrent vestibular Schwannoma (acoustic neuroma) following stereotactic radiosurgery. Otol Neurotol 27:213\u2013219","journal-title":"Otol Neurotol"},{"key":"9644_CR49","doi-asserted-by":"crossref","unstructured":"Pe\u0107ina-\u0160laus N, Zeljko M, Pe\u0107ina HI, Niku\u0161eva Marti\u0107 T, Ba\u010di\u0107 N, Tomas D, Hra\u0161\u0107an R (2012) Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients. Croat Med J 53:321\u2013327","DOI":"10.3325\/cmj.2012.53.321"},{"key":"9644_CR50","first-page":"1517","volume":"118","author":"LG Bian","year":"2005","unstructured":"Bian LG, Sun QF, Tirakotai W, Zhao WG, Shen JK, Luo QZ, Bertalanffy H (2005) Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells. Chin Med J (Engl) 118:1517\u20131524","journal-title":"Chin Med J (Engl)"},{"key":"9644_CR51","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1038\/onc.2010.363","volume":"29","author":"KD Hadfield","year":"2010","unstructured":"Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG (2010) Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29:6216\u20136221","journal-title":"Oncogene"},{"key":"9644_CR52","first-page":"615","volume":"22","author":"KK Mantripragada","year":"2003","unstructured":"Mantripragada KK, Buckley PG, Benetkiewicz M, De Bustos C, Hirvela C, Jarbo C, Bruder CE, Wensman H, Mathiesen T, Nyberg G, Papi L, Collins VP, Ichimura K, Evans G, Dumanski JP (2003) High-resolution profiling of an 11\u00a0Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH. Int J Oncol 22:615\u2013622","journal-title":"Int J Oncol"},{"key":"9644_CR53","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jmg.40.11.802","volume":"40","author":"C Warren","year":"2003","unstructured":"Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM, Evans DG (2003) Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridization. J Med Genet 40:802\u2013806","journal-title":"J Med Genet"},{"key":"9644_CR54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11060-010-0412-5","volume":"103","author":"D Koutsimpelas","year":"2011","unstructured":"Koutsimpelas D, Felmeden U, Mann WJ, Brieger J (2011) Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization. J Neurooncol 103:437\u2013443","journal-title":"J Neurooncol"},{"key":"9644_CR55","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1227\/NEU.0b013e3181ec7b71","volume":"67","author":"M Aarhus","year":"2010","unstructured":"Aarhus M, Bruland O, S\u00e6tran HA, Mork SJ, Lund-Johansen M, Knappskog PM (2010) Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas. Neurosurgery 67:998\u20131019","journal-title":"Neurosurgery"},{"key":"9644_CR56","first-page":"5995","volume":"59","author":"K Ueki","year":"1999","unstructured":"Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T (1999) Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res 59:5995\u20135998","journal-title":"Cancer Res"},{"key":"9644_CR57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.909","volume":"194","author":"J Kros","year":"2001","unstructured":"Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, Avezaat C, Lekane dit Deprez R, Zwarthoff E (2001) NF2 status of meningiomas is associated with tumour localization and histology. J Pathol 194:367\u2013372","journal-title":"J Pathol"},{"key":"9644_CR58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.pap.0000175117.47918.f7","volume":"12","author":"CE Fuller","year":"2005","unstructured":"Fuller CE, Perry A (2005) Molecular diagnostics in central nervous system tumors. Adv Anat Pathol 12:180\u2013194","journal-title":"Adv Anat Pathol"},{"key":"9644_CR59","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088\u20131094","journal-title":"Neurosurgery"},{"key":"9644_CR60","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","volume":"5","author":"MJ Riemenschneider","year":"2006","unstructured":"Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045\u20131054","journal-title":"Lancet Neurol"},{"key":"9644_CR61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109","journal-title":"Acta Neuropathol"},{"key":"9644_CR62","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1227\/01.NEU.0000141081.07086.A0","volume":"55","author":"JY Lee","year":"2004","unstructured":"Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT Jr, Omalu B (2004) Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 55:1163\u20131173","journal-title":"Neurosurgery"},{"key":"9644_CR63","first-page":"E9","volume":"119","author":"BT Ragel","year":"2005","unstructured":"Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 119:E9","journal-title":"Neurosurg Focus"},{"key":"9644_CR64","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC-07\/10\/E2","volume":"23","author":"JS Barnholtz-Sloan","year":"2007","unstructured":"Barnholtz-Sloan JS, Kruchko C (2007) Meningiomas: causes and risk factors. Neurosurg Focus 23:E2","journal-title":"Neurosurg Focus"},{"key":"9644_CR65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1227\/01.NEU.0000255421.78431.AE","volume":"60","author":"M Simon","year":"2007","unstructured":"Simon M, Bostr\u00f6m JP, Hartmann C (2007) Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery 60:787\u2013798","journal-title":"Neurosurgery"},{"key":"9644_CR66","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00432-009-0708-z","volume":"136","author":"N Pe\u0107ina-\u0160laus","year":"2010","unstructured":"Pe\u0107ina-\u0160laus N, Niku\u0161eva Marti\u0107 T, Deak AJ, Zeljko M, Hra\u0161\u0107an R (2010) Genetic and protein changes of E-cadherin in meningiomas. J Cancer Res Clin Oncol 136:695\u2013702","journal-title":"J Cancer Res Clin Oncol"},{"key":"9644_CR67","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/513207","volume":"80","author":"TJ Hulsebos","year":"2007","unstructured":"Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P (2007) Germline mutation of INI1\/SMARCB1 in familial Schwannomatosis. Am J Hum Genet 80:805\u2013810","journal-title":"Am J Hum Genet"},{"key":"9644_CR68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ajmg.a.35760","volume":"161","author":"SR Plotkin","year":"2013","unstructured":"Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, Kalpana GV, Korf B, Messiaen L, Papi L, Ratner N, Sherman LS, Smith MJ, Stemmer-Rachamimov AO, Vitte J, Giovannini M (2013) Update from the 2011 International Schwannomatosis Workshop: from genetics to diagnostic criteria. Am J Med Genet 161:405\u2013416","journal-title":"Am J Med Genet"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9644-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9644-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9644-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T19:26:13Z","timestamp":1645039573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9644-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,12]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["9644"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9644-y","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,12]]}}}